June 2017 PMID 28655021

The Diagnosis and Treatment of Prostate Cancer: A Review.

Mark S Litwin, Hung-Jui Tan

Download social card

Mentions

19
Peak: 2 in Nov 2019
across 6 sources since Nov 2019

Extended reach

68,308
potential audience

Total likes

330

Video views

18,570

Mentions per month

Nov 2019 – Dec 2024

Where it's discussed

  • Facebook6 posts
  • News5 articles
  • X / Twitter3 posts
  • YouTube2 videos
  • Blogs2 articles
  • Bluesky1 posts

AI synopsis

What people are saying

The overall tone reflects curiosity and recognition of ongoing advancements, such as AI’s role in prostate cancer diagnostics, with posts referencing the publication and including technical citations, indicating a thoughtful but not deeply critical or emotional engagement.

AgreementNeither agree nor disagree

The posts do not explicitly express agreement or disagreement with the article; rather, they show a neutral acknowledgement, especially by referencing the publication without critique.

InterestHigh interest

There is high interest shown in the topic, particularly with mentions of AI developments and sharing of the article's reference, indicating engagement with the subject matter.

EngagementModerate engagement

The discussions include technical references and prompts for comments, revealing a moderate level of engagement with the content and its implications.

ImpactNeutral impact

The overall impact appears limited as the discussion largely consists of sharing and referencing, without evidence of deep influence or advocacy for change.

Abstract in brief

  • Prostate cancer is the most common cancer in men and often progresses slowly, but it remains a leading cause of death, with diagnosis primarily through tissue biopsy.
  • Advances in imaging, biomarkers, and risk assessment have improved accuracy in identifying and classifying the disease, leading to more personalized treatment options.
  • Treatment strategies include active surveillance for less aggressive tumors, surgery and radiation for localized cancer, and chemotherapy or new hormonal and targeted therapies for advanced or resistant cases, all aiming to improve patient outcomes and quality of life.

Top posts

Most liked on X and Bluesky
Alberto
@almagoch · X

@Jorge_Salatiel 10.1001/jama.2017.7248 https://t.co/KQV6FObxrc

Nov 29, 2019 · 2 likes · 2 shares · 49,568 followers View post →
Isatou Sarr
@IsatouSarr4 · X

The Diagnosis and Treatment of Prostate Cancer: A Review https://t.co/U1XFt2KhuU

Jul 9, 2021 · 1 like · 48 followers View post →
Gil_Lpz_Vera
@dr_gilbertolpz · X

RT @almagoch: @Jorge_Salatiel 10.1001/jama.2017.7248 https://t.co/KQV6FObxrc

Nov 30, 2019 · 2 shares · 114 followers View post →
drtimos.bsky.social
@drtimos.bsky.social · Bluesky

Thoughts on this? >> Nucs AI Secures $3.5M to Advance AI-Powered Prostate Cancer Diagnostics: What You Should Know: – Nucs AI, a company that uses AI in precision medicine for the diagnosis and treatment of prostate cancer, today announces… >> Comment below! #industry40 #IoT #healthtech #AI #mhealth

Dec 11, 2024 View post →

All mentions

drtimos.bsky.social
@drtimos.bsky.social · Bluesky

Thoughts on this? >> Nucs AI Secures $3.5M to Advance AI-Powered Prostate Cancer Diagnostics: What You Should Know: – Nucs AI, a company that uses AI in precision medicine for the diagnosis and treatment of prostate cancer, today announces… >> Comment below! #industry40 #IoT #healthtech #AI #mhealth

Dec 11, 2024 View post →
Isatou Sarr
@IsatouSarr4 · X

The Diagnosis and Treatment of Prostate Cancer: A Review https://t.co/U1XFt2KhuU

Jul 9, 2021 · 1 like · 48 followers View post →
Gil_Lpz_Vera
@dr_gilbertolpz · X

RT @almagoch: @Jorge_Salatiel 10.1001/jama.2017.7248 https://t.co/KQV6FObxrc

Nov 30, 2019 · 2 shares · 114 followers View post →
Alberto
@almagoch · X

@Jorge_Salatiel 10.1001/jama.2017.7248 https://t.co/KQV6FObxrc

Nov 29, 2019 · 2 likes · 2 shares · 49,568 followers View post →